Table 2.
Characteristics of studies included in the lymphopenia mortality analysis cohort
| Study | Country & City | Sample Size | Cut-off (x10*9/l) | Survivors | Non-survivors | ||||||||||
| n (%) | Age (yrs)* | Women (%) |
Lymphopenia n (%) |
n (%) | Age (yrs)* | Women (%) |
Lymphopenia n (%) |
||||||||
| Zhou F et al., [26] | Wuhan, China | 191 | 0.8 | 137 (71.7%) | 52 (45-58) | 56 (41%) | 36 (26.3%) | 54 (28.3%) | 69 (63-76) | 16 (30%) | 41 (75.9%) | ||||
| Chen T et al., [27] | Wuhan, Chins | 274 | 0.5 | 161 (58.8%) | 51 (37-66) | 73 (45%) | 8 (5%) | 113 (41.2%) | 68 (62-77) | 30 (27%) | 44 (40%) | ||||
| 0.8 | 161 (58.8%) | 51 (37-66) | 73 (45%) | 48 (29.8%) | 113 (41.2%) | 68 (62-77) | 30 (27%) | 87 (78%) | |||||||
| 1 | 161 (58.8%) | 51 (37-66) | 73 (45%) | 76 (47.2%) | 113 (41.2%) | 68 (62-77) | 30 (27%) | 103 (91.2%) | |||||||
| Fan et al., [28] | Wuhan, China | 155 | 1.1 | 54 (34.8%) | - | - | 47 (87.0%) | 101 (65.2%) | 65.5±9.74 | 37 (37%) | 94 (93.1%) | ||||
| Yao et al., [22] | Dabieshan, China | 108 | 0.8 | 12 (11.1%) | - | - | 5 (41.7%) | 96 (88.9%) | 65.0 (51.0,73.5) |
5 (41%) | 18 (18.75%) | ||||
| Bonetti et al., [29] | Valcamonica, Italy | 144 | 0.5 | 74 (51.4%) | 62.1 (53-72.8) | 24 (31.1%) | 1 (1.4%) | 70 (48.6%) | 78 (64.2-84) | 25 (35.7%) | 13 (18.6%) | ||||
| 0.8 | 74 (51.4%) | 62.1 (53-72.8) | 24 (31.1%) | 17 (23%) | 70 (48.6%) | 78 (64.2-84) | 25 (35.7%) | 28 (40%) | |||||||
| 1.1 | 74 (51.4%) | 62.1 (53-72.8) | 24 (31.1%) | 22 (29.7%) | 70 (48.6%) | 78 (64.2-84) | 25 (35.7%) | 15 (21.4%) | |||||||